Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

this-incyte-analyst-begins-coverage-on-a-bullish-note;-here-are-top-2-initiations-for-friday-–-turning-point-brands-(nyse:tpb),-incyte-(nasdaq:incy)

This Incyte Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Friday – Turning Point Brands (NYSE:TPB), Incyte (NASDAQ:INCY)

Aug 1, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
barclays-initiates-coverage-on-incyte-stock-with-overweight-rating-by-investing.com

Barclays initiates coverage on Incyte stock with Overweight rating By Investing.com

Aug 1, 2025

Barclays initiates coverage on Incyte stock with Overweight rating

Read more
stock-analysis-|-texas-instruments-outlook-–-mixed-signals-amid-volatile-technicals-and-analyst-divergence

Stock Analysis | Texas Instruments Outlook – Mixed Signals Amid Volatile Technicals and Analyst Divergence

Aug 1, 2025

Data DriverFriday, Aug 1, 2025 1:56 am ET 3min read Market SnapshotTakeaway: Texas Instruments (TXN) is facing a…

Read more
raymond-james-assumes-coverage-on-bridgebio-stock-with-outperform-rating-by-investing.com

Raymond James assumes coverage on BridgeBio stock with Outperform rating By Investing.com

Aug 1, 2025

Raymond James assumes coverage on BridgeBio stock with Outperform rating

Read more
canadian-analyst-coverage-update:-july-29th,-2025

Canadian Analyst Coverage Update: July 29th, 2025

Aug 1, 2025

Analyst Ratings (Canada) AGF Management Ltd (AGF-B:CA) was rated “Hold” by Morningstar with a target price of $13.…

Read more
morgan-stanley-resumes-mp-materials-stock-coverage-with-equalweight-rating-by-investing.com

Morgan Stanley resumes MP Materials stock coverage with Equalweight rating By Investing.com

Aug 1, 2025

Morgan Stanley resumes MP Materials stock coverage with Equalweight rating

Read more
cantor-fitzgerald-assumes-coverage-on-avepoint-stock-with-overweight-rating-by-investing.com

Cantor Fitzgerald assumes coverage on Avepoint stock with Overweight rating By Investing.com

Aug 1, 2025

Cantor Fitzgerald assumes coverage on Avepoint stock with Overweight rating

Read more
this-lexeo-therapeutics-analyst-begins-coverage-on-a-bullish-note;-here-are-top-3-initiations-for-thursday-–-cytomx-therapeutics-(nasdaq:ctmx),-life360-(nasdaq:lif)

This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday – CytomX Therapeutics (NASDAQ:CTMX), Life360 (NASDAQ:LIF)

Jul 31, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
jpmorgan-assumes-coverage-of-aris-water-solutions-stock-with-neutral-rating-by-investing.com

JPMorgan assumes coverage of Aris Water Solutions stock with Neutral rating By Investing.com

Jul 31, 2025

JPMorgan assumes coverage of Aris Water Solutions stock with Neutral rating

Read more
ex-rockets-star-tracy-mcgrady-joining-nbc-as-studio-analyst

Ex-Rockets star Tracy McGrady joining NBC as studio analyst

Jul 31, 2025

Tracy McGrady, who had stints with ESPN and Turner Sports, is one of three former players hired as…

Read more
taglich-brothers-initiates-coverage-of-banzai-international,-inc.

Taglich Brothers Initiates Coverage of Banzai International, Inc.

Jul 31, 2025

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — Taglich Brothers, Inc. announces that it has initiated coverage of…

Read more
maxim-group-initiates-coverage-on-galaxy-digital-stock-with-buy-rating-by-investing.com

Maxim Group initiates coverage on Galaxy Digital stock with Buy rating By Investing.com

Jul 31, 2025

Maxim Group initiates coverage on Galaxy Digital stock with Buy rating

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 167
  6. 168
  7. 169
  8. 170
  9. 171
  10. 172
  11. 173
  12. ...
  13. 385
  14. »

Posts pagination

Newer posts Page 1 … Page 170 … Page 385 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.